Nanotechnology News and Research

RSS

Novel procedure opens door to new and future treatment for pancreatic cancer

Pancreatic cancer-known as the most fatal cancer with no known effective treatment-requires a radical new therapy. A promising approach may come in the form of tiny gold nanoparticles-loaded with a therapeutic agent to kill cancer-in a novel procedure called "nanoembolization," said researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

17 Mar 2010

Houston scientists unveil new technique for growing 3-D cell cultures

The film "Avatar" isn't the only 3-D blockbuster making a splash this winter. A team of Houston scientists this week unveiled a new technique for growing 3-D cell cultures, a technological leap from the flat petri dish that could save millions of dollars in drug-testing costs. The research is reported in Nature Nanotechnology.

16 Mar 2010

BeaconEquity.com: BPAX incurs net loss of $6.4M for quarter ended September 30, 2009

BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

12 Mar 2010

NIH awards Phase I SBIR grant to DNA Medicine Institute for emergency blood sensor

The DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced that it has been awarded a Phase I Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

9 Mar 2010

Nanoparticles: Targeted cancer therapy

Another weapon in the arsenal against cancer: Nanoparticles that identify, target and kill specific cancer cells while leaving healthy cells alone.

9 Mar 2010

Engineers built sensor array that can detect single molecules of hydrogen peroxide

MIT chemical engineers have built a sensor array that, for the first time, can detect single molecules of hydrogen peroxide emanating from a single living cell.

7 Mar 2010

Researchers discuss the synergy between nanoscience and neuroscience

Is it possible to build supercomputers that can replicate the human brain, or to develop nanotechnology that can lead to an implantable chip for interfacing with neurons and other types of cellular networks?

5 Mar 2010

Overview of nanotechnology: Nanoparticles may eventually be used in cosmetic products

The rapidly growing field of nanotechnology and its future use in cosmetic products holds both enormous potential and potential concern for consumers. Currently, major cosmetic manufacturers have imposed a voluntary ban on the use of nanoparticles in products while they await a ruling from the Food and Drug Administration regarding the safety of this technology.

5 Mar 2010

University of Calgary chemist finds potential tool to measure impact of nanoparticles on human health

University of Calgary chemistry professor David Cramb is a step closer to helping solve a complex problem in nanotechnology: the impact nanoparticles have on human health and the environment.

4 Mar 2010

Genetic Immunity to present data on DermaVir for HIV/AIDS at DNA Vaccines 2010

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine vaccines, will present data at this week’s DNA Vaccines 2010 in New Orleans, LA concerning the formulation and topical administration of the DermaVir therapeutic vaccine for HIV/AIDS. DNA Vaccine 2010 invites leading scientists to report on the latest research in the progressive field of DNA or Genetic Vaccines.

3 Mar 2010

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in 2010.

2 Mar 2010

NJIT researcher awarded patent for functional coating compositions of perfluoroalkyl perfluoro-phthalocyanine compounds

Sergiu M. Gorun, PhD, associate professor of chemistry at New Jersey Institute of Technology (NJIT), was awarded a patent today for a novel composition of matter. “Functional Coating Compositions of Perfluoroalkyl Perfluoro-Phthalocyanine Compounds” (US Patent Number 7,670,684) discloses a new self-contained subclass of molecules.

2 Mar 2010

Librede to develop technologies for improving ion channel drug discovery and screening at CNSI incubator

Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.

26 Feb 2010

Nanotechnology to tackle side effects and drug resistance in treatment of cancer

Huixin He, associate professor, nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, like bacteria, can develop resistance to drug therapy, leading to a relapse of the disease.

26 Feb 2010

Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting

Interventional radiologists-minimally invasive specialists-will share scientific advances and new discoveries in treating a host of diseases at the Society of Interventional Radiology's 35th Annual Scientific Meeting March 13󈝾 at the Tampa Convention Center, Tampa, Fla. This year's meeting theme is "IR Innovation"-one that celebrates the remarkable inventiveness of interventional radiologists.

25 Feb 2010

New genetic data may help predict risk for end-stage kidney disease

Israeli and American researchers have identified new genetic data that could be used in the future to predict who will develop end-stage kidney disease (ESKD). ESKD requires dialysis or transplantation to sustain life, and is fatal in most regions of the world, where these treatments are not available.

24 Feb 2010

Research paves way for building tabletop X-ray laser that can be used for high-resolution imaging

For nearly half a century, scientists have been trying to figure out how to build a cost-effective and reasonably sized X-ray laser that could, among other things, provide super high-resolution imaging. And for the past two decades, University of Colorado at Boulder physics professors Margaret Murnane and Henry Kapteyn have been inching closer to that goal.

22 Feb 2010

Nanotechnology could aid the future of development of Arab region, says TWAS

"Nanotechnology could aid the future of development of the Arab region," says Mohamed H.A. Hassan, executive director of TWAS, the academy of sciences for the developing world, and president of the African Academy of Sciences. Hassan made his remarks at a panel session, "Re-emergence of Science, Technology and Education as Priorities in the Arab World," taking place at the AAAS's annual meeting in San Diego.

22 Feb 2010

Nanotechnology plays a key role in detection and treatment of cancer

A world-renowned medical researcher discusses the key role that nanotechnology has begun to play in the detection and treatment of cancer in an article that will appear in the March 2010 edition of Mechanical Engineering magazine.

18 Feb 2010

NCI's NCL to conduct characterization studies of Celator Pharmaceuticals' HDPN formulation

Celator Pharmaceuticals today announced that the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), operated by SAIC-Frederick (Frederick, Maryland), has agreed to conduct characterization studies to advance the development of the company's nanoparticle drug formulation technology.

18 Feb 2010

Nanotechnology News and Research

Novel procedure opens door to new and future treatment for pancreatic cancer

Houston scientists unveil new technique for growing 3-D cell cultures

BeaconEquity.com: BPAX incurs net loss of $6.4M for quarter ended September 30, 2009

NIH awards Phase I SBIR grant to DNA Medicine Institute for emergency blood sensor

Nanoparticles: Targeted cancer therapy

Engineers built sensor array that can detect single molecules of hydrogen peroxide

Researchers discuss the synergy between nanoscience and neuroscience

Overview of nanotechnology: Nanoparticles may eventually be used in cosmetic products

University of Calgary chemist finds potential tool to measure impact of nanoparticles on human health

Genetic Immunity to present data on DermaVir for HIV/AIDS at DNA Vaccines 2010

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

NJIT researcher awarded patent for functional coating compositions of perfluoroalkyl perfluoro-phthalocyanine compounds

Librede to develop technologies for improving ion channel drug discovery and screening at CNSI incubator

Nanotechnology to tackle side effects and drug resistance in treatment of cancer

Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting

New genetic data may help predict risk for end-stage kidney disease

Research paves way for building tabletop X-ray laser that can be used for high-resolution imaging

Nanotechnology could aid the future of development of Arab region, says TWAS

Nanotechnology plays a key role in detection and treatment of cancer

NCI's NCL to conduct characterization studies of Celator Pharmaceuticals' HDPN formulation

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News